This mechanism of action was reported for the compound LC-0296 in head and neck squamous cell carcinoma (HNSCC), and for 3-TYP in acute myeloid leukemia (AML) [139,140]. The gene discussed is DUSP4; the disease is acute myeloid leukemia.